Selecta Biosciences

Sobi & Selecta Report Results of SEL-212 in P-II COMPARE Study for Chronic Refractory Gout

  • by

Shots:  The P-II COMPARE study assessing SEL-212 (once monthly) vs pegloticase (twice monthly) in 170 patients with chronic refractory gout SEL-212 showed a numerically higher response rate on 1EP during 3 & 6 mos., but didn’t meet 1EP of superiority, higher response rate during 3… Read More »Sobi & Selecta Report Results of SEL-212 in P-II COMPARE Study for Chronic Refractory Gout